• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国川崎病的流行病学:2015-2017 年全国调查。

Epidemiology of Kawasaki Disease in South Korea: A Nationwide Survey 2015-2017.

机构信息

From the Department of Pediatrics, Seoul National University Children's Hospital, Seoul.

Department of Pediatrics, Yonsei University Severance Hospital, Seoul.

出版信息

Pediatr Infect Dis J. 2020 Nov;39(11):1012-1016. doi: 10.1097/INF.0000000000002793.

DOI:10.1097/INF.0000000000002793
PMID:33075217
Abstract

BACKGROUND

This study aimed to investigate recent epidemiologic features of Kawasaki disease (KD) in South Korea.

METHODS

The ninth triennial nationwide questionnaire survey collected data on the demographic findings, symptoms and signs, treatment patterns and coronary artery complications of acute-phase KD occurred in 2015-2017 from 98 hospitals with pediatric residency programs and 108 community hospitals without residency programs.

RESULTS

We received data from 93 of the 98 hospitals (response rate: 94.9%) with residency programs and 75 of the 108 community-based children's hospitals (response rate: 69.4%) without residency programs. In the 3-year survey period, a total of 15,378 (5449 in 2015, 5171 in 2016 and 4758 in 2017) cases of KD were reported. The mean age at diagnosis was 33.0 ± 24.8 months (range: 0-205 months), and the male-to-female ratio was 1.41:1. The overall KD incidence was 196.9 (202.2 in 2015, 197.1 in 2016 and 191.0 in 2017) per 100,000 younger than 5 years population. Recurrent cases were 4.85%. KD occurred more frequently during winter (December-January) and late spring (May-June). Intravenous immunoglobulin (IVIG) was administered to 95% of the patients; nonresponder rate for the first IVIG was 14.8%. Coronary artery aneurysms and giant coronary artery aneurysms (internal diameter >8 mm) occurred in 1.7% and 19 patients, respectively. Two patients died due to multiorgan failure and hepatic encephalopathy.

CONCLUSION

Peak incidence of KD in South Korea was 202.2 per 100,000 younger than 5 years population (2015), and the incidence of giant coronary artery aneurysm decreased to 0.09% (2017).

摘要

背景

本研究旨在调查韩国川崎病(KD)的最新流行病学特征。

方法

第九次三年一度的全国问卷调查收集了 2015-2017 年期间 98 家有儿科住院医师培训计划的医院和 108 家无住院医师培训计划的社区医院中急性川崎病的人口统计学发现、症状和体征、治疗模式和冠状动脉并发症的数据。

结果

我们收到了 98 家有住院医师培训计划的医院中的 93 家(回应率:94.9%)和 108 家无住院医师培训计划的社区儿童医院中的 75 家(回应率:69.4%)的数据。在 3 年的调查期间,共报告了 15378 例(2015 年 5449 例,2016 年 5171 例,2017 年 4758 例)川崎病病例。诊断时的平均年龄为 33.0±24.8 个月(范围:0-205 个月),男女比例为 1.41:1。总川崎病发病率为 196.9(2015 年 202.2,2016 年 197.1,2017 年 191.0)/100000 以下 5 岁人群。复发病例为 4.85%。川崎病在冬季(12 月-1 月)和晚春(5 月-6 月)更为常见。95%的患者接受了静脉注射免疫球蛋白(IVIG)治疗;首次 IVIG 无反应率为 14.8%。冠状动脉瘤和巨大冠状动脉瘤(内径>8mm)分别发生在 1.7%和 19 例患者中。有 2 例患者因多器官衰竭和肝性脑病死亡。

结论

韩国川崎病的发病高峰为每 100000 名 5 岁以下儿童发病 202.2 例(2015 年),巨大冠状动脉瘤的发病率下降至 0.09%(2017 年)。

相似文献

1
Epidemiology of Kawasaki Disease in South Korea: A Nationwide Survey 2015-2017.韩国川崎病的流行病学:2015-2017 年全国调查。
Pediatr Infect Dis J. 2020 Nov;39(11):1012-1016. doi: 10.1097/INF.0000000000002793.
2
Epidemiology and Clinical Features of Kawasaki Disease in South Korea, 2012-2014.2012 - 2014年韩国川崎病的流行病学及临床特征
Pediatr Infect Dis J. 2017 May;36(5):482-485. doi: 10.1097/INF.0000000000001474.
3
Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011.韩国川崎病的流行病学特征:2009 - 2011年全国性调查数据
Pediatr Infect Dis J. 2014 Jan;33(1):24-7. doi: 10.1097/INF.0000000000000010.
4
Nationwide survey of coronary aneurysms with diameter >6 mm in Kawasaki disease in Korea.韩国川崎病中直径>6毫米冠状动脉瘤的全国性调查。
Pediatr Int. 2015 Jun;57(3):367-72. doi: 10.1111/ped.12536. Epub 2015 Jan 16.
5
Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.土耳其儿童川崎病:单中心经验,重点关注静脉注射免疫球蛋白抵抗和巨大冠状动脉瘤
Turk J Pediatr. 2019;61(5):648-656. doi: 10.24953/turkjped.2019.05.002.
6
Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.急性川崎病后巨大冠状动脉瘤的流行病学和危险因素。
Pediatr Cardiol. 2021 Apr;42(4):969-977. doi: 10.1007/s00246-021-02571-8. Epub 2021 Mar 8.
7
Unexpectedly high incidence of Kawasaki Disease in a Canadian Atlantic Province- an 11-year retrospective descriptive study.加拿大大西洋省份川崎病发病率异常增高——一项 11 年回顾性描述性研究。
Pediatr Rheumatol Online J. 2023 Apr 3;21(1):30. doi: 10.1186/s12969-023-00805-y.
8
Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.2013 年至 2017 年上海川崎病的流行病学特征。
J Epidemiol. 2020 Oct 5;30(10):429-435. doi: 10.2188/jea.JE20190065. Epub 2019 Sep 21.
9
Five years of Kawasaki disease in the Netherlands: a national surveillance study.荷兰川崎病五年:一项全国性监测研究。
Pediatr Infect Dis J. 2014 Aug;33(8):793-7. doi: 10.1097/INF.0000000000000271.
10
Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.川崎病所致巨大冠状动脉瘤的病例对照研究:第19次全国性调查
Pediatr Int. 2010 Oct;52(5):790-4. doi: 10.1111/j.1442-200X.2010.03161.x.

引用本文的文献

1
A retrospective cohort study using machine learning to predict coronary artery lesions in children with Kawasaki disease.一项利用机器学习预测川崎病患儿冠状动脉病变的回顾性队列研究。
BMC Pediatr. 2025 Jul 31;25(1):583. doi: 10.1186/s12887-025-05917-w.
2
Clinical value of combined detection of serum ferritin and N-terminal pro-brain natriuretic peptide in the assessment of Kawasaki disease in children over 1 year of age.血清铁蛋白与N末端脑钠肽前体联合检测在1岁以上儿童川崎病评估中的临床价值
Ital J Pediatr. 2025 Jul 15;51(1):229. doi: 10.1186/s13052-025-02076-7.
3
Limited Performance of Machine Learning Models Developed Based on Demographic and Laboratory Data Obtained Before Primary Treatment to Predict Coronary Aneurysms.
基于初次治疗前获得的人口统计学和实验室数据开发的机器学习模型预测冠状动脉瘤的性能有限。
Biomedicines. 2025 Apr 29;13(5):1073. doi: 10.3390/biomedicines13051073.
4
The Comparative Effectiveness of Intravenous Immunoglobulin and Corticosteroids in Kawasaki Disease: A Nationwide Claim Data Analysis.静脉注射免疫球蛋白和皮质类固醇治疗川崎病的比较效果:一项全国性索赔数据分析
J Clin Med. 2025 Mar 16;14(6):2012. doi: 10.3390/jcm14062012.
5
The incidence of periungual desquamation and thrombocytosis in Kawasaki disease and the importance of systematic observation in the subacute phase.川崎病中指甲周围脱皮和血小板增多症的发生率以及亚急性期系统观察的重要性。
Front Pediatr. 2024 Jul 8;12:1384015. doi: 10.3389/fped.2024.1384015. eCollection 2024.
6
Overview of childhood vasculitis.儿童血管炎概述。
J Rheum Dis. 2024 Jul 1;31(3):135-142. doi: 10.4078/jrd.2024.0045. Epub 2024 Jun 5.
7
Sex-Specific Susceptibility Loci Associated With Coronary Artery Aneurysms in Patients With Kawasaki Disease.川崎病患者冠状动脉瘤相关的性别特异性易感基因座。
Korean Circ J. 2024 Sep;54(9):577-586. doi: 10.4070/kcj.2023.0244. Epub 2024 Apr 8.
8
Incidence and seasonality of Kawasaki disease in children in the Philippines, and its association with ambient air temperature.菲律宾儿童川崎病的发病率、季节性及其与环境气温的关系。
Front Pediatr. 2024 Apr 22;12:1358638. doi: 10.3389/fped.2024.1358638. eCollection 2024.
9
Decreased incidence of Kawasaki disease in South Korea during the SARS-CoV-2 pandemic.韩国在新冠病毒大流行期间川崎病发病率下降。
Front Pediatr. 2024 Apr 3;12:1307931. doi: 10.3389/fped.2024.1307931. eCollection 2024.
10
Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review.目前关于 TNF-α 单克隆抗体英夫利昔单抗治疗川崎病的知识:全面综述。
Front Immunol. 2023 Oct 23;14:1237670. doi: 10.3389/fimmu.2023.1237670. eCollection 2023.